These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28782332)

  • 1. Virological outcomes of antiretroviral therapy in Zomba central prison, Malawi; a cross-sectional study.
    Mpawa H; Kwekwesa A; Amberbir A; Garone D; Divala OH; Kawalazira G; van Schoor V; Ndindi H; van Oosterhout JJ
    J Int AIDS Soc; 2017 Aug; 20(1):21623. PubMed ID: 28782332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
    Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
    BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges with targeted viral load testing for medical inpatients at Queen Elizabeth Central Hospital in Blantyre, Malawi.
    Craik A; Patel P; Patel P; Mallewa J; Malisita K; Bitilinyu-Bangoh J; van Oosterhout JJ; Kelly C
    Malawi Med J; 2016 Dec; 28(4):179-181. PubMed ID: 28321282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV viral suppression in TREAT Asia HIV Observational Database enrolled adults on antiretroviral therapy at the Social Health Clinic, the National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
    Boettiger DC; Khol V; Durier N; Law M; Sun LP
    Antivir Ther; 2016; 21(8):725-730. PubMed ID: 27124891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy.
    Silveira MP; Silveira CP; Guttier MC; Page K; Moreira LB
    J Clin Pharm Ther; 2016 Dec; 41(6):689-694. PubMed ID: 27676134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
    Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
    J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
    Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
    J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015.
    Bulage L; Ssewanyana I; Nankabirwa V; Nsubuga F; Kihembo C; Pande G; Ario AR; Matovu JK; Wanyenze RK; Kiyaga C
    BMC Infect Dis; 2017 May; 17(1):326. PubMed ID: 28468608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal antiretroviral therapy adherence as evaluated by CASE index score tool is associated with virological suppression in HIV-infected adults in Dakar, Senegal.
    Byabene AK; Fortes-Déguénonvo L; Niang K; Manga MN; Bulabula ANH; Nachega JB; Seydi M
    Trop Med Int Health; 2017 Jun; 22(6):776-782. PubMed ID: 28407436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.
    Boyd MA; Moore CL; Molina JM; Wood R; Madero JS; Wolff M; Ruxrungtham K; Losso M; Renjifo B; Teppler H; Kelleher AD; Amin J; Emery S; Cooper DA;
    Lancet HIV; 2015 Feb; 2(2):e42-51. PubMed ID: 26424460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study.
    White BL; Golin CE; Grodensky CA; Kiziah CN; Richardson A; Hudgens MG; Wohl DA; Kaplan AH
    AIDS Behav; 2015 Jan; 19(1):128-36. PubMed ID: 25055766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A targeted approach for routine viral load monitoring in Malawian adults on antiretroviral therapy.
    Mungwira RG; Divala TH; Nyirenda OM; Kanjala M; Muwalo F; Mkandawire FA; Choko A; Taylor TE; Mallewa J; van Oosterhout JJ; Laufer MK; Laurens MB
    Trop Med Int Health; 2018 May; 23(5):526-532. PubMed ID: 29505108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study.
    Nsanzimana S; Semakula M; Ndahindwa V; Remera E; Sebuhoro D; Uwizihiwe JP; Ford N; Tanner M; Kanters S; Mills EJ; Bucher HC
    BMC Infect Dis; 2019 Apr; 19(1):312. PubMed ID: 30953449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained virological response and drug resistance among female sex workers living with HIV on antiretroviral therapy in Kampala, Uganda: a cross-sectional study.
    Namale G; Kamacooko O; Bagiire D; Mayanja Y; Abaasa A; Kilembe W; Price M; Ssemwanga D; Lunkuse S; Nanyonjo M; Ssenyonga W; Mayaud P; Newton R; Kaleebu P; Seeley J
    Sex Transm Infect; 2019 Sep; 95(6):405-411. PubMed ID: 31266818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.
    Schoffelen AF; Wensing AM; Tempelman HA; Geelen SP; Hoepelman AI; Barth RE
    PLoS One; 2013; 8(3):e58526. PubMed ID: 23505529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
    Hermans LE; Moorhouse M; Carmona S; Grobbee DE; Hofstra LM; Richman DD; Tempelman HA; Venter WDF; Wensing AMJ
    Lancet Infect Dis; 2018 Feb; 18(2):188-197. PubMed ID: 29158101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.
    Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A
    BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2014 Apr; 26(4):448-53. PubMed ID: 24215157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dried blood spots for viral load monitoring in Malawi: feasible and effective.
    Rutstein SE; Hosseinipour MC; Kamwendo D; Soko A; Mkandawire M; Biddle AK; Miller WC; Weinberger M; Wheeler SB; Sarr A; Gupta S; Chimbwandira F; Mwenda R; Kamiza S; Hoffman I; Mataya R
    PLoS One; 2015; 10(4):e0124748. PubMed ID: 25898365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.